Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.
Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, Li J, Shehadeh LA, Hare JM, David V, Martin A, Fornoni A, Di Marco GS, Kentrup D, Reuter S, Mayer AB, Pavenstädt H, Stypmann J, Kuhn C, Hille S, Frey N, Leifheit-Nestler M, Richter B, Haffner D, Abraham R, Bange J, Sperl B, Ullrich A, Brand M, Wolf M, Faul C. Grabner A, et al. Among authors: di marco gs. Cell Metab. 2015 Dec 1;22(6):1020-32. doi: 10.1016/j.cmet.2015.09.002. Epub 2015 Oct 1. Cell Metab. 2015. PMID: 26437603 Free PMC article.
FGF23 induces left ventricular hypertrophy.
Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M. Faul C, et al. Among authors: di marco gs. J Clin Invest. 2011 Nov;121(11):4393-408. doi: 10.1172/JCI46122. Epub 2011 Oct 10. J Clin Invest. 2011. PMID: 21985788 Free PMC article.
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.
Grabner A, Schramm K, Silswal N, Hendrix M, Yanucil C, Czaya B, Singh S, Wolf M, Hermann S, Stypmann J, Di Marco GS, Brand M, Wacker MJ, Faul C. Grabner A, et al. Among authors: di marco gs. Sci Rep. 2017 May 16;7(1):1993. doi: 10.1038/s41598-017-02068-6. Sci Rep. 2017. PMID: 28512310 Free PMC article.
The soluble VEGF receptor sFlt1 contributes to endothelial dysfunction in CKD.
Di Marco GS, Reuter S, Hillebrand U, Amler S, König M, Larger E, Oberleithner H, Brand E, Pavenstädt H, Brand M. Di Marco GS, et al. J Am Soc Nephrol. 2009 Oct;20(10):2235-45. doi: 10.1681/ASN.2009010061. Epub 2009 Jul 16. J Am Soc Nephrol. 2009. PMID: 19608702 Free PMC article.
Soluble Flt-1 links microvascular disease with heart failure in CKD.
Di Marco GS, Kentrup D, Reuter S, Mayer AB, Golle L, Tiemann K, Fobker M, Engelbertz C, Breithardt G, Brand E, Reinecke H, Pavenstädt H, Brand M. Di Marco GS, et al. Basic Res Cardiol. 2015 May;110(3):30. doi: 10.1007/s00395-015-0487-4. Epub 2015 Apr 21. Basic Res Cardiol. 2015. PMID: 25893874
Damage of the endothelial glycocalyx in chronic kidney disease.
Padberg JS, Wiesinger A, di Marco GS, Reuter S, Grabner A, Kentrup D, Lukasz A, Oberleithner H, Pavenstädt H, Brand M, Kümpers P. Padberg JS, et al. Among authors: di marco gs. Atherosclerosis. 2014 Jun;234(2):335-43. doi: 10.1016/j.atherosclerosis.2014.03.016. Epub 2014 Mar 29. Atherosclerosis. 2014. PMID: 24727235
40 results